Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 681 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $22.62, for a total transaction of $15,404.22. Following the sale, the insider owned 2,187,110 shares in the company, valued at approximately $49,472,428.20. This trade represents a 0.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Healthcare Holding B.V. Gilde also recently made the following trade(s):
- On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
- On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
- On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
- On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total value of $166,132.32.
- On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
- On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
- On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
- On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.
Shoulder Innovations Stock Up 0.8%
Shoulder Innovations stock opened at $22.24 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.92 and a current ratio of 10.71. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The company has a 50-day simple moving average of $21.03 and a 200-day simple moving average of $16.60. The firm has a market capitalization of $463.02 million and a P/E ratio of -11.58.
Shoulder Innovations (NYSE:SI - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The firm had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, equities analysts expect that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. Roubaix Capital LLC lifted its holdings in Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company's stock valued at $3,736,000 after acquiring an additional 98,305 shares during the last quarter. Sectoral Asset Management Inc. grew its stake in shares of Shoulder Innovations by 14.4% in the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company's stock worth $7,042,000 after purchasing an additional 62,153 shares during the last quarter. Royal Bank of Canada grew its stake in shares of Shoulder Innovations by 7,046.3% in the 1st quarter. Royal Bank of Canada now owns 53,883 shares of the company's stock worth $783,000 after purchasing an additional 53,129 shares during the last quarter. KCM Capital Inc bought a new stake in shares of Shoulder Innovations in the 1st quarter worth approximately $509,000. Finally, Compass Financial Management LLC acquired a new stake in Shoulder Innovations during the second quarter valued at approximately $30,000.
Analyst Ratings Changes
Several analysts recently commented on SI shares. BTIG Research raised their target price on Shoulder Innovations from $24.00 to $26.00 and gave the company a "buy" rating in a research report on Friday, August 7th. UBS Group increased their price target on Shoulder Innovations from $27.00 to $28.00 and gave the stock a "buy" rating in a research note on Monday, August 10th. Weiss Ratings raised Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a report on Monday, August 3rd. Finally, Piper Sandler reiterated an "overweight" rating and issued a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a research report on Friday, August 7th. Five analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $25.50.
Get Our Latest Analysis on Shoulder Innovations
Shoulder Innovations Company Profile
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
